Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial

In the context of suspected neonatal sepsis, early diagnosis and stratification of patients according to clinical severity is not yet effectively achieved. In this diagnostic trial, we aimed to assess the accuracy of presepsin (PSEP) for the diagnosis and early stratification of supposedly septic ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietrasanta, Carlo, Ronchi, Andrea, Vener, Claudia, Poggi, Chiara, Ballerini, Claudia, Testa, Lea, Colombo, Rosaria Maria, Spada, Elena, Dani, Carlo, Mosca, Fabio, Pugni, Lorenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156848/
https://www.ncbi.nlm.nih.gov/pubmed/34068959
http://dx.doi.org/10.3390/antibiotics10050580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156848/
https://www.ncbi.nlm.nih.gov/pubmed/34068959
http://dx.doi.org/10.3390/antibiotics10050580

Ejemplares similares